Episode 59: Using Tau to Target Alzheimer’s

June 25, 2020
Christen Harm

Christen Harm is Pharmaceutical Executive's Associate Editor. Email her at charm@mmhgroup.com

,
Elaine Quilici

Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at equilici@mmh.com

Pharmaceutical Executive

Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.

Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.

You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.

 

Pharmaceutical Executive Magazine

·

Episode 59: Using Tau to Target Alzheimer’s

Related Content:

Editorial Podcasts